权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

A Systems Approach to Improve Safe Medication Management for Children with Medical Complexity

改善医疗复杂性儿童安全用药管理的系统方法

基本信息

批准号：
10449831
负责人：
Ephrem Abebe
金额：
$ 12.98万
依托单位：
PURDUE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-05-13 至 2026-01-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10449831
关键词：
Academy Address Adopted Adult American Award Behavioral Model Caregivers Caring Child Childhood Complex Consolidated Framework for Implementation Research Data Discharge Plannings Effectiveness Engineering Ensure Evaluation Research Failure Family Family Caregiver Foundations Future Goals Health Personnel Healthcare Healthcare Systems Home Hospitals Human Hybrids Individual Intervention Interview Joints Knowledge Laws Literature Maps Measures Medicaid Medical Medication Management Modeling Output Participant Patient Self-Report Patients Pediatrics Performance Persons Pharmaceutical Preparations Phase Professional Role Randomized Controlled Trials Recommendation Regimen Reporting Research Research Personnel Resources Risk Role Safety Schedule Solid Specific qualifier value Statutes and Laws System Technology Testing Training United States National Institutes of Health Work base care coordination career development cost design evidence base experience future implementation high risk hospital readmission human centered design implementation research improved medication safety patient oriented patient population patient safety pediatric patients prevent prototype safe patient skill acquisition success successful intervention therapy design therapy development tool usability

项目摘要

PROJECT SUMMARY The proposed research addresses a key patient safety gap among children with medical complexity (CMC) transitioning between hospital and home—medication related harm. CMC are often on multiple and complex medication regimens and have intensive healthcare needs. As a result, they experience frequent transitions of care, across professional roles and care settings and during these transitions, CMC are at great risk for medication-related harm. Most transitional care interventions have been adopted from adult care settings and may not be adequate to address the unique needs of CMC and their family caregivers. Interventions that are grounded in the unique situations and complexities of such patients are needed to improve medication use safety and family experience of care. This proposal describes the PI’s plan to transition into an independent investigator by developing expertise in 1) participatory, human centered design to co-develop useful interventions, and 2) implementing and evaluating interventions. The proposal also describes a 4-year project for developing a prototype care transition medication safety intervention and generating early evidence on its usability and potential factors influencing its future implementation. Aim 1: Patient journey mapping—will be used to elucidate medication safety risks and contexts during the hospital-to-home transition period. Journey maps will be used to capture and visually represent the medication use experience of families across professional settings and boundaries. The output of this aim will inform prototype design under Aim 2. Aim 2: Participatory, human centered design to co-design a prototype medication safety intervention. Through multiple, iterative co-design sessions involving healthcare workers and family caregivers, a team will design a prototype medication safety intervention informed by journey maps from Aim 1, current literature, and participant elicitations. The result will be a composite prototype ready for usability testing. Aim 3: Will test usability of prototype intervention with healthcare workers and family caregivers. Additionally, barriers and facilitators that may be anticipated during future prototype implementation will be explored. Taken together, all 3 aims will yield a final, refined prototype intervention designed to improve medication use safety during care transitions. Future work will include a randomized controlled trial of the prototype medication safety intervention to formally evaluate it effectiveness in preventing or reducing medication related harm as well as improving the medication use experience of CMC and their family caregivers.

项目总结